Citigroup’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,100,775
| Closed | -$16.7M | – | 6166 |
|
|
2022
Q3 | $16.7M | Sell |
1,100,775
-53,848
| -5% | -$626K | 0.01% | 889 |
|
|
2022
Q2 | $8.66M | Sell |
1,154,623
-52,683
| -4% | -$371K | 0.01% | 1227 |
|
|
2022
Q1 | $11M | Buy |
1,207,306
+127,969
| +12% | +$986K | 0.01% | 1254 |
|
|
2021
Q4 | $7.58M | Sell |
1,079,337
-174,993
| -14% | -$1.83M | ﹤0.01% | 1569 |
|
|
2021
Q3 | $14.3M | Buy |
1,254,330
+13,506
| +1% | +$197K | 0.01% | 1204 |
|
|
2021
Q2 | $19.9M | Buy |
1,240,824
+67,658
| +6% | +$1.16M | 0.01% | 1003 |
|
|
2021
Q1 | $21M | Sell |
1,173,166
-75,532
| -6% | -$1.3M | 0.01% | 927 |
|
|
2020
Q4 | $16.9M | Buy |
1,248,698
+44,827
| +4% | +$542K | 0.01% | 1151 |
|
|
2020
Q3 | $14.2M | Sell |
1,203,871
-7,297
| -0.6% | -$88.9K | 0.01% | 1123 |
|
|
2020
Q2 | $17.9M | Buy |
1,211,168
+39,669
| +3% | +$587K | 0.01% | 887 |
|
|
2020
Q1 | $15.8M | Buy |
1,171,499
+250,518
| +27% | +$4.75M | 0.01% | 867 |
|
|
2019
Q4 | $22.3M | Buy |
920,981
+919,922
| +86,867% | +$19.1M | 0.02% | 903 |
|
|
2019
Q3 | $20K | Sell |
1,059
-9,920
| -90% | -$227K | ﹤0.01% | 6749 |
|
|
2019
Q2 | $324K | Buy |
10,979
+4,719
| +75% | +$182K | ﹤0.01% | 4853 |
|
|
2019
Q1 | $297K | Sell |
6,260
-45,665
| -88% | -$2.01M | ﹤0.01% | 4717 |
|
|
2018
Q4 | $1.88M | Sell |
51,925
-43,747
| -46% | -$2.05M | ﹤0.01% | 2739 |
|
|
2018
Q3 | $5.89M | Buy |
95,672
+32,605
| +52% | +$2.1M | 0.01% | 1706 |
|
|
2018
Q2 | $4.26M | Buy |
63,067
+23,845
| +61% | +$1.33M | ﹤0.01% | 1991 |
|
|
2018
Q1 | $2.13M | Sell |
39,222
-43,544
| -53% | -$2.44M | ﹤0.01% | 2541 |
|
|
2017
Q4 | $4.95M | Buy |
82,766
+61,389
| +287% | +$3.72M | ﹤0.01% | 1848 |
|
|
2017
Q3 | $1.04M | Buy |
21,377
+32
| +0.1% | +$1.75K | ﹤0.01% | 3337 |
|
|
2017
Q2 | $1.12M | Sell |
21,345
-181,932
| -89% | -$8.47M | ﹤0.01% | 3193 |
|
|
2017
Q1 | $9.22M | Buy |
203,277
+63,198
| +45% | +$2.82M | 0.01% | 1190 |
|
|
2016
Q4 | $5.3M | Buy |
140,079
+122,707
| +706% | +$4.64M | ﹤0.01% | 1776 |
|
|
2016
Q3 | $656K | Buy |
17,372
+7,557
| +77% | +$167K | ﹤0.01% | 3649 |
|
|
2016
Q2 | $172K | Sell |
9,815
-10,517
| -52% | -$170K | ﹤0.01% | 4628 |
|
|
2016
Q1 | $248K | Buy |
20,332
+7,126
| +54% | +$113K | ﹤0.01% | 4875 |
|
|
2015
Q4 | $322K | Buy |
13,206
+6,912
| +110% | +$161K | ﹤0.01% | 4296 |
|
|
2015
Q3 | $112K | Buy |
6,294
+756
| +14% | +$13.7K | ﹤0.01% | 4898 |
|
|
2015
Q2 | $98K | Sell |
5,538
-1,976
| -26% | -$36.2K | ﹤0.01% | 5014 |
|
|
2015
Q1 | $235K | Buy |
7,514
+364
| +5% | +$10.6K | ﹤0.01% | 4392 |
|
|
2014
Q4 | $209K | Buy |
7,150
+5,413
| +312% | +$137K | ﹤0.01% | 4655 |
|
|
2014
Q3 | $36K | Buy |
1,737
+1,648
| +1,852% | +$32.5K | ﹤0.01% | 5528 |
|
|
2014
Q2 | $2K | Sell |
89
-3,685
| -98% | -$63.8K | ﹤0.01% | 6799 |
|
|
2014
Q1 | $80K | Buy |
3,774
+3
| +0.1% | +$61 | ﹤0.01% | 5185 |
|
|
2013
Q4 | $68K | Buy |
+3,771
| New | +$49.1K | ﹤0.01% | 5540 |
|
Citigroup's AERI Position: Q4 2022 in Review
Citigroup sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,100,775 shares — an estimated $16.7M sold.
Citigroup first reported a position in AERI in Q4 2013 and held it in 36 quarters. The position peaked at $22.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Citigroup reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Citigroup sold 1,100,775 Aerie Pharmaceuticals shares in Q4 2022, an estimated $16.7M.
- Citigroup first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 36 quarters.
- Citigroup's Aerie Pharmaceuticals position peaked at $22.3M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.